Invitris
Creating new protein-based drugs at scale
If you are part of Invitris (or you are a YC founder who looks at Invitris and thinks that is the kind of business I run), you probably do not have time for a six-month SEO agency contract. Seoable was built for that. Audit your site, queue 100 ready-to-publish posts, and run it all from your AI assistant.
About Invitris
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Quick facts
- YC Batch
- Winter 2023
- Founded
- 2022
- Headquarters
- Munich, Germany
- Team size
- 6
- Industry
- Healthcare • Healthcare -> Drug Discovery and Delivery
- Tags
- biotech, nanotechnology, drug-discovery
- Website
- invitris.com
- Profiles
Founders
Why founders like Invitris use Seoable
- Ship without an agency. Audit your site and queue 100 posts in one afternoon. No briefs to write, no calls to take.
- Drive it from Claude or Cursor. Seoable is MCP-first. Your assistant can run audits, queue posts, and pull reports without you opening a dashboard.
- Pay per piece, not per seat. Credits instead of monthly seats. Buy what you need, when you need it.
- SEO that includes AI engines. Our audits check what ChatGPT, Claude, Perplexity, Gemini, DeepSeek, and Grok already say about you, not just Google.